Adamax: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 13 sources cited

Overview

Adamax is sold as a modified derivative of Semax carrying an adamantane group, meant to give better blood-brain barrier penetration and a longer half-life. No study of it has been published: its synthesis, pharmacokinetics and effects appear nowhere in the scientific literature, so everything below comes from work on Semax and other peptides. Users in the nootropic community report improved focus, verbal fluency, mental clarity, and motivation, with effects often described as cleaner and more sustained than the parent compound Semax.

Mechanism of Action

Adamax works through multiple converging neurotrophin and neurotransmitter pathways. As a derivative of the ACTH(4-10) melanocortin fragment, it retains the core sequence's ability to upregulate brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, particularly in the hippocampus and prefrontal cortex — regions critical for memory consolidation and executive function. Adding an adamantane group is a known way to make a peptide more lipophilic and slower to be cut by exopeptidases, and it was used for that purpose in the CNTF-derived peptide P021. For Adamax itself, no measurement of brain penetration or half-life has been published, so the comparison with unmodified Semax is an assumption. Semax binds specifically to membranes from the rat basal forebrain and influences serotonergic and dopaminergic transmission, though no study has shown which melanocortin receptors it or Adamax acts on. In rat cell culture Semax raised the survival of cholinergic basal forebrain neurons and stimulated choline acetyltransferase activity, and in ischemic rat brain it increased active CREB while lowering MMP-9, c-Fos and active JNK. No study has measured antioxidant enzymes such as SOD or catalase under Semax or Adamax.

Adamax Benefits: What the Research Shows

  • A single intranasal dose of Semax raised exon III BDNF mRNA threefold and BDNF protein 1.4-fold in the rat hippocampus, with the gene changes varying by region and time point.
  • Russian clinical studies on the parent compound Semax reported faster recovery of motor function and daily activities in stroke patients during rehabilitation, alongside higher plasma BDNF.
  • ACTH(4-7)PGP derivatives protected rat brain tissue after transient middle cerebral artery occlusion, leaving more surviving neurons around the infarct and more proliferating neuroglia and blood vessels in the penumbra.
  • Adding an adamantyl group was used to make the CNTF-derived peptide P021 blood-brain-barrier permeable and resistant to exopeptidases, which is the published basis for the approach; no study reports a penetration figure for adamantane-modified Semax.
  • Semax showed antidepressant-like effects in chronically stressed rats, reversing anhedonia and the fall in hippocampal BDNF, though it did not change immobility in the forced swim test.

Adamax Dosage

  • Intranasal administration: 100–300 mcg per nostril, 1–2 times daily. This is the most common route for nootropic use, providing rapid onset (5–15 minutes) via the olfactory mucosa.
  • Subcutaneous injection: 100–500 mcg once daily, typically in the morning. Provides more consistent bioavailability than intranasal.
  • Start with the lowest effective dose (100 mcg) for the first 3–5 days to assess individual response and tolerance.
  • Standard cycle: 2–4 weeks on, 2 weeks off. Extended cycles of up to 6 weeks are reported but lack safety data.
  • Best used in the morning or early afternoon. Avoid evening dosing as enhanced dopaminergic and noradrenergic activity may interfere with sleep onset.
  • Can be combined with NA-Selank-Amidate (intranasal) for a balanced cognitive-anxiolytic stack, using Adamax for focus and Selank for calm.
  • Onset of effects: intranasal 5–15 minutes, subcutaneous 15–30 minutes. Duration: 4–8 hours depending on dose and route.
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

Adamax Side Effects & Safety

Known Side Effects

  • Nasal irritation or mild burning sensation with intranasal use — most common side effect, typically mild and transient.
  • Headache — reported occasionally, particularly during the first few days of use or at higher doses.
  • Insomnia or sleep disruption if taken too late in the day, related to enhanced catecholaminergic activity.
  • Mild anxiety or overstimulation in sensitive individuals, particularly at doses above 300 mcg. Dose reduction usually resolves this.
  • Transient hair shedding — reported anecdotally by a subset of users, possibly related to melanocortin receptor modulation affecting the hair growth cycle. Reversible upon discontinuation.
  • Appetite changes — some users report reduced appetite, consistent with melanocortin system activation.

Safety Profile

Adamax has no safety data of its own, and no toxicology on it has been published. Its parent compound Semax has been used in Russia since the 1990s and was reported as well tolerated in small trials, while FDA records that it has no, or limited, safety information for Semax itself. Adamantane derivatives (such as memantine, amantadine) have well-characterized safety profiles in other pharmaceutical applications. Contraindications include a history of seizure disorders (melanocortin peptides may lower seizure threshold at high doses), active psychotic conditions, and pregnancy/breastfeeding. Individuals with anxiety disorders should start at the lowest dose, as enhanced catecholaminergic activity may initially exacerbate anxiety. Long-term safety data specific to Adamax (as opposed to Semax) is limited. Caution with stimulants is warranted: in rats Semax sharply amplified amphetamine's effect on dopamine release and locomotion.

What to Expect

Days 1–3: Initial effects are noticeable within 15–30 minutes of first dose — improved verbal fluency, mental clarity, and a sense of cognitive 'sharpness.' Effects are subtle but distinctly present. Some users notice enhanced color perception or auditory clarity. Days 4–7: The nootropic effects deepen as BDNF upregulation takes hold. Working memory, task switching, and sustained attention improve. Verbal articulation becomes notably smoother. The cognitive enhancement feels more consistent day-to-day. Weeks 2–3: Peak effects are typically reached during this period. Users report the strongest improvements in focus, creativity, and mental stamina. Mood elevation and motivation are commonly noted. Some users report vivid dreams. Week 4+: Effects maintain at a steady state with continued use. Upon cycling off, residual benefits in cognitive function may persist for 1–2 weeks, likely reflecting sustained BDNF elevation. Tolerance does not appear to develop significantly within a 4-week cycle.

Common Stacks

Storage & Handling

Store lyophilized powder refrigerated at 36–46°F (2–8°C). Protect from light. Reconstituted nasal spray solutions should be refrigerated and used within 30 days. For subcutaneous use, reconstitute with bacteriostatic water, refrigerate, and use within 21 days. Unreconstituted powder has a shelf life of approximately 18–24 months when stored properly. Avoid repeated freeze-thaw cycles.

Pricing & Available Variants

$60price range
10mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006.
  2. Agapova TY, Agniullin YV, Shadrina MI, et al. Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Neurosci Lett. 2007.
  3. Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the tretament of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018.
  4. Gusev EI, Skvortsova VI, Miasoedov NF, et al. Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). Zh Nevrol Psikhiatr Im S S Korsakova. 1997.
  5. Stavchansky VV, Yuzhakov VV, Sevan'kaeva LE, et al. Melanocortin Derivatives Induced Vascularization and Neuroglial Proliferation in the Rat Brain under Conditions of Cerebral Ischemia. Curr Issues Mol Biol. 2024.
  6. Sudarkina OY, Filippenkov IB, Stavchansky VV, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH((4-7))PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. Int J Mol Sci. 2021.
  7. Dmitrieva VG, Povarova OV, Skvortsova VI, et al. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010.
  8. Grivennikov IA, Dolotov OV, Zolotarev YA, et al. Effects of behaviorally active ACTH (4-10) analogue - Semax on rat basal forebrain cholinergic neurons. Restor Neurol Neurosci. 2008.
  9. Eremin KO, Kudrin VS, Saransaari P, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005.
  10. Inozemtseva LS, Yatsenko KA, Glazova NY, et al. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress. Eur J Pharmacol. 2024.
  11. Baazaoui N, Iqbal K. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. Alzheimers Res Ther. 2017.
  12. Khatoon S, Chalbot S, Bolognin S, et al. Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound. J Alzheimers Dis. 2015.
  13. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. 2026.

Related Peptides

Track Adamax in Your Protocol

Log your Adamax doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free